Citations

Clear

6728 citation(s) found for "Li, Mark".

Spontaneous fusion of cells between species yields transdifferentiation and retroviral transfer in vivo
Ogle, Brenda M. , Butters, Kim A., Plummer, Timothy B., Ring, Kevin R., Litzow, Mark R. , Platt, Jeffrey L. , Knudsen, Bruce E. , Cascalho, Marília

Mayo Clinic

The FASEB Journal | January 12, 2004 | Volume: 18 | Issue: 3 | Pages: 548-550

10.1096/fj.03-0962fje | PMID 14715691 Get It

Human cells can fuse with damaged or diseased somatic cells in vivo. Whether human cells fuse in vivo in the absence of disease and with cells of disparate species is unknown. Such a question is of current interest because blood exchanges between species through direct physical contact, via insect vectors or parasitism, are thought to underlie the transmission of zoonotic agents. In a model of human‐pig chimerism, we show that some human hematopoietic stem cells engrafted in pigs contain both human and porcine chromosomal DNA. These hybrid cells divide, express human and porcine proteins, and contribute to porcine nonhematopoietic tissues. In addition, the hybrid cells contain porcine endogenous retroviral DNA sequences and are able to transmit this virus to uninfected human cells in vitro. Thus, spontaneous fusion can occur in vivo between the cells of disparate species and in the absence of disease. The ability of these cell hybrids to acquire and transmit retroviral elements together with their ability to integrate into tissues could explain genetic recombination and generation of novel pathogens.
Nitric Oxide Synthase Inhibition by L-NAME Prevents Brain Acidosis during Focal Cerebral Ischemia in Rabbits
Held, Mark C., Meyer, Fredric B. , Regli, Luca , Anderson, Robert E.

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | November 18, 2003 | Volume: 16 | Issue: 5 | Pages: 988-995

10.1097/00004647-199609000-00024 | PMID 8784244 Get It

This experiment examined the effects of nitric oxide (NO) synthase inhibition on brain intracellular pH, regional cortical blood flow, and NADH fluorescence before and during 3 h of focal cerebral ischemia using in vivo fluorescence imaging. Thirty fasted rabbits under 1% halothane were divided into four treatment groups receiving N ω -nitro-L-arginine methyl ester (L-NAME) intravenously at 20 min prior to ischemia (0.1, I, and 10 mg/kg and 1 mg/kg + 5 mg/kg L-arginine) and two control groups (nonischemic and ischemic). In ischemic controls, brain pH i declined to 6.73 ± 0.03 at 30 min and remained acidotic through the remainder of the ischemic period. In the 0.1 mg/kg group, brain pH i fell after 30 min of ischemia to 6.76 ± 0.05 ( p < 0.05), but then improved progressively despite occlusion. In the 1 mg/kg group, brain pH i remained normal despite middle cerebral artery (MCA) occlusion. In the 10 mg/kg group and in the combined L-NAME + L-arginine group, pH i fell after 30 min of ischemia to 6.81 ± 0.03 ( p < 0.05) and remained acidotic. During occlusion, regional cortical blood flow dropped in a dose-dependent manner. After 3 h of ischemia, regional cortical blood flow was 33.9 ± 10.9 and 25.1 ± 8.9 ml/100 g/min at doses of 0.1 and 10.0 mg/kg, respectively. L-NAME treatment did not significantly alter the increased NADH fluorescence that accompanied occlusion. This study shows that L-NAME can prevent intracellular brain acidosis during focal cerebral ischemia independent from regional cortical blood flow changes. This experiment suggests that NO is involved in pH i regulation during focal cerebral ischemia.
Durability of Carotid Endarterectomy
Ecker, Robert D., Pichelmann, Mark A., Meissner, Irene, Meyer, Fredric B.

Mayo Clinic

Stroke | November 18, 2003 | Volume: 34 | Issue: 12 | Pages: 2941-2944

10.1161/01.str.0000098903.93992.49 | PMID 14615627 Get It

Background and Purpose—We sought to determine the incidence of recurrent stenosis after carotid endarterectomy.Methods—One thousand consecutive carotid endarterectomy patients were followed prospectively. The surgery was performed in a standard fashion. Cerebral protection was provided with intraoperative electroencephalographic monitoring and selective shunting. All arteriotomies were repaired with a patch graft. Each patient was seen 3 months after surgery and then yearly, with a duplex ultrasound obtained at each visit. Evidence for new ischemic events or recurrent stenosis of ≥70% was recorded.Results—The 30-day combined minor and major stroke and death rate was 1.9%. At 7.1-year follow-up, 0.1% of patients had recurrent stenosis ≥70%, the majority of which were asymptomatic.Conclusions—Carotid endarterectomy is a low-risk procedure for the treatment of carotid occlusive disease, with excellent long-term durability. Although less invasive, carotid angioplasty must demonstrate equal robustness in long-term follow-up before it is considered a routine alternative to surgery.
Cell-Type-Specific Activation of PAK2 by Transforming Growth Factor β Independent of Smad2 and Smad3
Wilkes, Mark C. , Garamszegi, Nandor, Leof, Edward B. , Murphy, Stephen J.

Mayo Clinic

Molecular and Cellular Biology | November 11, 2003 | Volume: 23 | Issue: 23 | Pages: 8878-8889

10.1128/mcb.23.23.8878-8889.2003 | PMID 14612425 Get It

Neuropathy following Axillary Brachial Plexus Block: Is It the Tourniquet?
Jankowski, Christopher J., Keegan, Mark T. , Bolton, Charles F., Harrison, Barry

Mayo Clinic

Anesthesiology | November 10, 2003 | Volume: 99 | Issue: 5 | Pages: 1230-1232

10.1097/00000542-200311000-00036 | PMID 14576566 Get It

Pneumatic Compression Boots, Lithotomy Stirrups, and Lower Limb Compartment Syndrome
Warner, Mark A. , Halliwill, John R.

Mayo Clinic

Anesthesiology | November 10, 2003 | Volume: 97 | Issue: 1 | Pages: 285-285

10.1097/00000542-200207000-00055 Get It

Fatal Hepatitis Associated with Isoflurane Exposure and CYP2A6 Autoantibodies
Martin, Jackie L. , Keegan, Mark T. , Vasdev, G., Nyberg, Scott L. , Bourdi, Mohammed, Pohl, Lance R., Plevak, David J.

Mayo Clinic

Anesthesiology | November 10, 2003 | Volume: 95 | Issue: 2 | Pages: 551-553

10.1097/00000542-200108000-00043 | PMID 11506133 Get It

Compartment Syndrome in Surgical Patients
Warner, Mary E. , LaMaster, Lisa M., Thoeming, Amy K., Marienau, Mary E. Shirk, Warner, Mark A.

Mayo Clinic

Anesthesiology | November 10, 2003 | Volume: 94 | Issue: 4 | Pages: 705-708

10.1097/00000542-200104000-00026 | PMID 11379693 Get It

Osteogenesis Imperfecta, Perioperative Bleeding, and Desmopressin
Keegan, Mark T. , Whatcott, Brett D., Harrison, Barry

Mayo Clinic

Anesthesiology | November 10, 2003 | Volume: 97 | Issue: 4 | Pages: 1011-1013

10.1097/00000542-200210000-00039 | PMID 12357173 Get It

Comparison of Blood-conservation Strategies in Cardiac Surgery Patients at High Risk for Bleeding
Nuttall, Gregory A. , Oliver, William C., Ereth, Mark H. , Santrach, Paula J., Bryant, Sandra C. , Orszulak, Thomas A., Schaff, Hartzell V.

Mayo Clinic

Anesthesiology | November 10, 2003 | Volume: 92 | Issue: 3 | Pages: 674-682

10.1097/00000542-200003000-00010 | PMID 10719945 Get It

Background Aprotinin and tranexamic acid are routinely used to reduce bleeding in cardiac surgery. There is a large difference in agent price and perhaps in efficacy. Methods In a prospective, randomized, partially blinded study, 168 cardiac surgery patients at high risk for bleeding received either a full-dose aprotinin infusion, tranexamic acid (10-mg/kg load, 1-mg x kg(-1) x h(-1) infusion), tranexamic acid with pre-cardiopulmonary bypass autologous whole-blood collection (12.5% blood volume) and reinfusion after cardiopulmonary bypass (combined therapy), or saline infusion (placebo group). Results There were complete data in 160 patients. The aprotinin (n = 40) and combined therapy (n = 32) groups (data are median [range]) had similar reductions in blood loss in the first 4 h in the intensive care unit (225 [40-761] and 163 [25-760] ml, respectively; P = 0.014), erythrocyte transfusion requirements in the first 24 h in the intensive care unit (0 [0-3] and 0 [0-3] U, respectively; P = 0.004), and durations of time from end of cardiopulmonary bypass to discharge from the operating room (92 [57-215] and 94 [37, 186] min, respectively; P = 0.01) compared with the placebo group (n = 43). Ten patients in the combined therapy group (30.3%) required transfusion of the autologous blood during cardiopulmonary bypass for anemia. Conclusions The combination therapy of tranexamic acid and intraoperative autologous blood collection provided similar reduction in blood loss and transfusion requirements as aprotinin. Cost analyses revealed that combined therapy and tranexamic acid therapy were the least costly therapies.